• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

We are pleased to announce that the UK’s Oncogene Cancer Research has now joined the LuCE family.
Its mission is to increase the life expectancy of people living with oncogene-driven cancers that originate in the lungs.
Each year hundreds of thousands of people are diagnosed with an oncogene-driven lung cancer such as ALK, EGFR, RET, ROS1, KRAS and others.
Those diagnosed are often younger and many have no known risk factors. These oncogene-driven cancers can also appear elsewhere in the body and benefit from many of the same drugs.
Oncogene Cancer Research is focused on funding research to increase life expectancy – and one day find a cure.
They have a growing number of members and its senior representatives include:
➡️ Yvonne Diaz, Chair and Co-founder
➡️ Jan Clark, Secretary and Co-founder
➡️ Helen Tankard, Trustee
Find out more here: https://www.oncogeneresearch.org/patient-advocacy